Results 1 to 3 of 3

Thread: 4 FDA approvals this Q (Mcap 96 Mil) Hot Pick 2011

  1. Default 4 FDA approvals this Q (Mcap 96 Mil) Hot Pick 2011

    Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.

  2. Default

    This stock is still significantly Undervalued . Anik awaiting 4 FDA approvals including one potential Blockbuster(Monovisc) , the first Approval could push this stock to $15+ .I think we could see $30+ with all FDA approvals . Anika is definitely one of the best Biotech Investment .GL

  3. Default

    Pullback creates a great buying opportunity .This stock will defintely move up with all these FDA approvals ahead .GL

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •